Genotoxicity Testing Market

In vitro genotoxicity testing is estimated at 46.0% by service in 2026, with pharmaceuticals at 43.0% by application and in vitro testing at 54.0% by test type. Accepted regulatory batteries support routine testing, but equivocal signals require additional interpretation and targeted follow-up.